Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: Multilevel analysis

被引：20

作者：

Gezie L.D. ^{[1
]}

机构：

[1] Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar

来源：

BMC Research Notes | / 9卷 / 1期

关键词：

ART; CD4; count; Linear mixed method; Multilevel analysis;

D O I：

10.1186/s13104-016-2182-4

中图分类号：

学科分类号：

摘要：

Background: The response of HIV patients to antiretroviral therapy could be measured by its strong predictor, the CD4+ T cell (CD4) count for the initiation of antiretroviral therapy and proper management of disease progress. However, in addition to HIV, there are other factors which can influence the CD4 cell count. Patient's socio-economic, demographic, and behavioral variables, accessibility, duration of treatment etc., can be used to predict CD4 count. Methods: A retrospective cohort study was conducted to examine the predictors of CD4 count among ART users enrolled in the first 6 months of 2010 and followed upto mid 2014. The covariance components model was employed to determine the predictors of CD4 count over time. Results: A total of 1196 ART attendants were used to analyze their data descriptively. Eight hundred sixty-one of the attendants had two or more CD4 count measurements and were used in modeling their data using the linear mixed method. Thus, the mean rates of incensement of CD4 counts for patients with ambulatory/bedridden and working baseline functional status were 17.4 and 30.6 cells/mm3 per year, respectively. After adjusting for other variables, for each additional baseline CD4 count, the gain in CD4 count during treatment was 0.818 cells/mm3 (p value <0.001). Patient's age and baseline functional status were also statistically significantly associated with CD4 count. Conclusion: In this study, higher baseline CD4 count, younger age, working functional status, and time in treatment contributed positively to the increment of the CD4 count. However, the observed increment at 4 year was unsatisfactory as the proportion of ART users who reached the normal range of CD4 count was very low. To see their long term treatment outcome, it requires further research with a sufficiently longer follow up data. In line with this, the local CD4 count for HIV negative persons should also be investigated for better comparison and proper disease management. © 2016 Gezie.

引用

共 38 条

[1]

Ethiopian Demographic and Health Survey, (2011)

[2]

Mellors J.W., Munoz A., Giorgi J.V., Margolick J.B., Tassoni C.J., Gupta P., Et al., Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection, Ann Intern Med, 126, pp. 946-954, (1997)

[3]

Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents, pp. 1-167, (2011)

[4]

Kaufmann R.G., Perrin L., Pantaleo G., Opravil M., Furrer H., Telenti A., Et al., CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: The Swiss HIV cohort study, Arch Intern Med, 163, 18, pp. 2187-2195, (2003)

[5]

Montarroyos R.U., Miranda-Filho C.D., Cesar C.C., Souza V.W., Lacerda R.H., Albuquerque M.P., Et al., Factors related to changes in CD4+ T-Cell counts over time in patients living with HIV/AIDS: A multilevel analysis, PLoS ONE, 9, 2, (2014)

[6]

Florence E., Lundgren J., Dreezen C., Fischer M., Kirk O., Blaxhult A., Et al., Factors associated with a reduced CD4+ lymphocyte count response to HAART despite full viral suppression in the Euro SIDA study, HIV Med., 4, 3, pp. 255-262, (2003)

[7]

Addisu A., Dagim A., Tadele E., Adissu A., Mussie A., Filmon K., CD4 cell count trends after commencement of antiretroviral therapy among HIV infected patients in Tigray, northern Ethiopia: A retrospective cross-sectional study, PLoS ONE, 10, 3, (2015)

[8]

Smith J.C., Sabin A.C., Youle S.M., Loes K.S., Lampe C.F., Madge S., Et al., Factors influencing increases in CD4 cell counts of HIV positive persons receiving long-term highly active antiretroviral therapy, J Infect Dis, 190, pp. 1860-1868, (2004)

[9]

Ebonyi O.A., Agbaji O.O., Anejo-Okopi A.J., Oguche S., Agaba A.P., Sagay S.A., Et al., Factors associated with a low CD4 count among HIV-1 infected patients at enrolment into HAART in Jos, Nigeria, Br J Med Res, 4, 13, pp. 2536-2545, (2014)

[10]

Bonjour M.A., Montagne M., Zambrano M., Molina G., Lippuner C., Wadskier F.G., Et al., Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: A case-case comparison, AIDS Res Ther, 5, (2008)

← 1 2 3 4 →